XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -10.33%1.37B | -10.33%1.37B | 0.89%1.47B | 4.71%1.66B | -4.98%1.6B | -6.57%1.53B | -6.57%1.53B | -9.78%1.46B | -5.16%1.59B | -3.16%1.69B |
-Cash and cash equivalents | -5.86%506.2M | -5.86%506.2M | 84.71%543.8M | 100.17%572.5M | 94.63%536.6M | 174.34%537.7M | 174.34%537.7M | -31.02%294.4M | 17.79%286M | 5.59%275.7M |
-Short-term investments | -12.76%865.7M | -12.76%865.7M | -20.35%925.6M | -16.30%1.09B | -24.45%1.07B | -31.17%992.3M | -31.17%992.3M | -2.14%1.16B | -9.06%1.3B | -4.70%1.41B |
Receivables | 10.81%728.8M | 10.81%728.8M | 10.39%391.9M | 10.47%456.7M | 8.66%386.3M | 2.10%657.7M | 2.10%657.7M | 15.79%355M | 20.17%413.4M | 7.30%355.5M |
-Accounts receivable | 10.81%728.8M | 10.81%728.8M | 10.39%391.9M | 10.47%456.7M | 8.66%386.3M | 2.10%657.7M | 2.10%657.7M | 15.79%355M | 20.17%413.4M | 7.30%355.5M |
Other current assets | 32.43%92.7M | 32.43%92.7M | 70.22%90.9M | 37.02%75.5M | 44.34%79.1M | 40.00%70M | 40.00%70M | 2.50%53.4M | 0.18%55.1M | -0.54%54.8M |
Total current assets | -2.85%2.19B | -2.85%2.19B | 4.68%1.95B | 6.74%2.19B | -1.38%2.07B | -3.18%2.26B | -3.18%2.26B | -5.48%1.86B | -0.81%2.05B | -1.46%2.1B |
Non current assets | ||||||||||
Net PPE | 0.50%80.8M | 0.50%80.8M | -1.10%80.6M | 3.06%80.8M | -0.62%79.6M | -2.90%80.4M | -2.90%80.4M | -1.09%81.5M | -7.00%78.4M | -3.61%80.1M |
-Gross PPE | ---- | ---- | ---- | ---- | ---- | 9.46%214M | 9.46%214M | ---- | ---- | ---- |
-Accumulated depreciation | ---- | ---- | ---- | ---- | ---- | -18.54%-133.6M | -18.54%-133.6M | ---- | ---- | ---- |
Goodwill and other intangible assets | 8.50%1.9B | 8.50%1.9B | 7.93%1.9B | 33.52%1.72B | 34.27%1.74B | 34.97%1.75B | 34.97%1.75B | 35.58%1.76B | -0.98%1.29B | -1.02%1.29B |
-Goodwill | ---- | ---- | ---- | ---- | ---- | 25.69%1.55B | 25.69%1.55B | ---- | ---- | ---- |
-Other intangible assets | ---- | ---- | ---- | ---- | ---- | 230.10%194.1M | 230.10%194.1M | ---- | ---- | ---- |
Investments and advances | -1.25%1.41B | -1.25%1.41B | -8.41%1.4B | -27.58%1.4B | -25.87%1.43B | -23.37%1.43B | -23.37%1.43B | -21.64%1.53B | -3.71%1.93B | -6.11%1.93B |
Non current deferred assets | -22.25%63.6M | -22.25%63.6M | 20.47%76.5M | 30.40%88.8M | 27.83%91.4M | 5.41%81.8M | 5.41%81.8M | -22.28%63.5M | -2.99%68.1M | 11.37%71.5M |
Other non current assets | -0.82%96.6M | -0.82%96.6M | 0.51%99.5M | 40.14%100.2M | 41.30%99.9M | 36.22%97.4M | 36.22%97.4M | 29.58%99M | -12.16%71.5M | -18.08%70.7M |
Total non current assets | 3.26%3.55B | 3.26%3.55B | 0.66%3.56B | -1.41%3.39B | -0.25%3.44B | 1.32%3.44B | 1.32%3.44B | 1.22%3.54B | -2.97%3.44B | -4.18%3.45B |
Total assets | 0.84%5.74B | 0.84%5.74B | 2.05%5.51B | 1.64%5.58B | -0.68%5.51B | -0.51%5.7B | -0.51%5.7B | -1.20%5.4B | -2.17%5.49B | -3.17%5.54B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | ---- | ---- | ---- | ---- | ---- | 29.06%93.7M | 29.06%93.7M | ---- | ---- | ---- |
-accounts payable | ---- | ---- | ---- | ---- | ---- | 63.18%48.3M | 63.18%48.3M | ---- | ---- | ---- |
-Total tax payable | ---- | ---- | ---- | ---- | ---- | 18.66%40.7M | 18.66%40.7M | ---- | ---- | ---- |
-Other payable | ---- | ---- | ---- | ---- | ---- | -45.98%4.7M | -45.98%4.7M | ---- | ---- | ---- |
Current accrued expenses | ---- | ---- | ---- | ---- | ---- | 1.34%408.6M | 1.34%408.6M | ---- | ---- | ---- |
Current deferred liabilities | 4.07%1.47B | 4.07%1.47B | 1.92%1.27B | 2.65%1.34B | 2.43%1.35B | 3.70%1.41B | 3.70%1.41B | 5.62%1.25B | 7.97%1.31B | 7.55%1.32B |
Current liabilities | 1.47%1.94B | 1.47%1.94B | -0.31%1.72B | 1.48%1.79B | 1.58%1.78B | 4.18%1.92B | 4.18%1.92B | 7.12%1.72B | 5.57%1.76B | 6.25%1.75B |
Non current liabilities | ||||||||||
Non current deferred liabilities | 7.11%529M | 7.11%529M | 2.64%474.8M | 2.01%476.5M | -0.60%478.9M | -3.99%493.9M | -3.99%493.9M | -0.94%462.6M | 2.61%467.1M | 8.61%481.8M |
Other non current liabilities | 13.73%32.3M | 13.73%32.3M | 32.83%35.2M | 73.91%36M | 61.90%34M | 27.93%28.4M | 27.93%28.4M | 18.83%26.5M | -17.86%20.7M | -27.08%21M |
Total non current liabilities | 5.36%1.01B | 5.36%1.01B | 7.99%967.8M | 6.86%966M | 4.28%958.9M | 0.22%958.4M | 0.22%958.4M | -5.24%896.2M | -1.80%904M | -1.10%919.5M |
Total liabilities | 2.77%2.95B | 2.77%2.95B | 2.53%2.68B | 3.30%2.75B | 2.51%2.74B | 2.83%2.87B | 2.83%2.87B | 2.54%2.62B | 2.95%2.66B | 3.60%2.67B |
Shareholders'equity | ||||||||||
Share capital | 0.00%800K | 0.00%800K | 0.00%800K | 0.00%800K | 0.00%800K | 0.00%800K | 0.00%800K | 0.00%800K | 0.00%800K | 0.00%800K |
-common stock | 0.00%800K | 0.00%800K | 0.00%800K | 0.00%800K | 0.00%800K | 0.00%800K | 0.00%800K | 0.00%800K | 0.00%800K | 0.00%800K |
Retained earnings | 6.42%14.01B | 6.42%14.01B | 6.48%13.76B | 6.57%13.55B | 6.71%13.35B | 6.82%13.17B | 6.82%13.17B | 7.14%12.92B | 7.07%12.71B | 6.94%12.51B |
Paid-in capital | 11.72%3.05B | 11.72%3.05B | 12.56%3.02B | 11.88%2.93B | 9.93%2.81B | 9.27%2.73B | 9.27%2.73B | 9.15%2.68B | 8.98%2.62B | 8.53%2.55B |
Less: Treasury stock | 9.40%14.27B | 9.40%14.27B | 9.53%13.95B | 9.66%13.62B | 10.24%13.35B | 10.50%13.04B | 10.50%13.04B | 10.88%12.73B | 11.20%12.42B | 11.62%12.11B |
Gains losses not affecting retained earnings | 73.72%-10.3M | 73.72%-10.3M | 98.57%-1.2M | 60.81%-35.7M | 51.77%-39.4M | 59.96%-39.2M | 59.96%-39.2M | 28.06%-84.1M | -3.76%-91.1M | -47.21%-81.7M |
Total stockholders'equity | -1.12%2.79B | -1.12%2.79B | 1.59%2.83B | 0.07%2.83B | -3.65%2.77B | -3.70%2.82B | -3.70%2.82B | -4.47%2.78B | -6.55%2.83B | -8.73%2.87B |
Total equity | -1.12%2.79B | -1.12%2.79B | 1.59%2.83B | 0.07%2.83B | -3.65%2.77B | -3.70%2.82B | -3.70%2.82B | -4.47%2.78B | -6.55%2.83B | -8.73%2.87B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |